NL8002809A - Nieuwe estreno2,3-ddihydroisoxazooldiolen en bereiding daarvan, alsmede farmaceutische preparaten (die deze verbindingen bevatten). - Google Patents

Nieuwe estreno2,3-ddihydroisoxazooldiolen en bereiding daarvan, alsmede farmaceutische preparaten (die deze verbindingen bevatten). Download PDF

Info

Publication number
NL8002809A
NL8002809A NL8002809A NL8002809A NL8002809A NL 8002809 A NL8002809 A NL 8002809A NL 8002809 A NL8002809 A NL 8002809A NL 8002809 A NL8002809 A NL 8002809A NL 8002809 A NL8002809 A NL 8002809A
Authority
NL
Netherlands
Prior art keywords
compound
methyl
formula
grams
compounds
Prior art date
Application number
NL8002809A
Other languages
English (en)
Dutch (nl)
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of NL8002809A publication Critical patent/NL8002809A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0063Nitrogen and oxygen at position 2(3)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
NL8002809A 1979-05-17 1980-05-14 Nieuwe estreno2,3-ddihydroisoxazooldiolen en bereiding daarvan, alsmede farmaceutische preparaten (die deze verbindingen bevatten). NL8002809A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4006579A 1979-05-17 1979-05-17
US4006579 1979-05-17

Publications (1)

Publication Number Publication Date
NL8002809A true NL8002809A (nl) 1980-11-19

Family

ID=21908897

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8002809A NL8002809A (nl) 1979-05-17 1980-05-14 Nieuwe estreno2,3-ddihydroisoxazooldiolen en bereiding daarvan, alsmede farmaceutische preparaten (die deze verbindingen bevatten).

Country Status (10)

Country Link
JP (1) JPS55160798A (fr)
AU (1) AU5797480A (fr)
BE (1) BE883335A (fr)
DE (1) DE3018903A1 (fr)
DK (1) DK214980A (fr)
FR (1) FR2456748A1 (fr)
GB (1) GB2051816A (fr)
IT (1) IT1151085B (fr)
NL (1) NL8002809A (fr)
SE (1) SE8003656L (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2590358B2 (ja) * 1988-03-01 1997-03-12 正雄 五十嵐 子宮内膜症治療用の子宮内又は膣内投与製剤

Also Published As

Publication number Publication date
DE3018903A1 (de) 1980-11-27
AU5797480A (en) 1980-11-20
SE8003656L (sv) 1980-11-18
IT8022087A1 (it) 1981-11-15
JPS55160798A (en) 1980-12-13
FR2456748A1 (fr) 1980-12-12
IT8022087A0 (it) 1980-05-15
DK214980A (da) 1980-11-18
BE883335A (fr) 1980-11-17
GB2051816A (en) 1981-01-21
IT1151085B (it) 1986-12-17

Similar Documents

Publication Publication Date Title
EP1776378B1 (fr) Procédé de fabrication de dérivés 2-substitués d"estrone et d"estradiol
DK163520B (da) Substitueret androsta-1,4-dien-3,17-dioner, fremgangsmaade til fremstilling deraf, praeparater indeholdende saadanne forbindelser samt anvendelsen af disse til fremstilling af farmaceutiske praeparater
JPH02503194A (ja) 19,11β―架橋ステロイド,その製造法および該化合物を含有する製薬学的調剤
KR0142881B1 (ko) 성스테로이드 활성 억제용 에스트로겐 핵유도체
WO2006003012A1 (fr) NOUVEAUX D-HOMO-ESTRA-1,3,5(10)-TRIENES 2-SUBSTITUES SERVANT D'INHIBITEURS DE LA 17ß-HYDROXYSTEROIDE-DESHYDROGENASE DE TYPE 1
US20120282331A1 (en) Mammalian metabolites of steroids
EP0988311B9 (fr) Derives de betulinol
EP1580192A2 (fr) 16-Hydroxyestratrienes servant d'estrogènes agissant de manière sélective
US3159543A (en) 3-cyclopentyl and cyclopentenyl ethers of estrone and derivatives thereof
TW200909444A (en) 17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative
NL8002809A (nl) Nieuwe estreno2,3-ddihydroisoxazooldiolen en bereiding daarvan, alsmede farmaceutische preparaten (die deze verbindingen bevatten).
WO1993013122A1 (fr) 3-methylsulfonylhydrazono- et 3-oxyimino-steroides, leur procede de fabrication, preparations pharmaceutiques renfermant ces steroides et leur utilisation dans la fabrication de medicaments
DE4042007A1 (de) 6,7-modifizierte-11(beta)-aryl-4-estrene
HUT54707A (en) Process for producing 14,17-etheno- and -etheno-estratrienes and pharmaceutical compositions containing them
NZ336224A (en) Steroids substituted in position 11, method of preparation, application as medicines and pharmaceutical compositions containing them
Ismail et al. Novel Steroidal 1, 4‐Diketones and Pyridazine Derivatives as Potential Antiestrogens
JP3541008B2 (ja) 不飽和14,15−シクロプロパノ−アンドロスタン、その製造法および該化合物を含有する製薬学的調製剤
US3868452A (en) 17Alpha-ethynylestriol 3-Cyclopentyl ether
NZ200779A (en) 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha
RU2244718C2 (ru) Ненасыщенные 14,15-циклопропаноандростаны, способ их получения, соединения, фармацевтическая композиция
US3717663A (en) 9-alpha-methyl steroids
US3462465A (en) 6,7-methylene steroids
IL32699A (en) 6-substituted-13-polycarbonalkyl-18,19 dinorpregn-4-en-3-ones,their preparation and pharmaceutical compositions containing them
EP1418921B1 (fr) Sulfamates de 2-alkoxyestradiol presentant une action antitumorale
NO860177L (no) 17a-beta-hydroksy-7 alfa-metyl-d-homo-19-norandrost-4,16-dien-3-on- og 17a-beta-hydroksyestere derav, deres fremstilling og anvendelser.

Legal Events

Date Code Title Description
BV The patent application has lapsed